{"protocolSection": {"identificationModule": {"nctId": "NCT00624065", "orgStudyIdInfo": {"id": "COR111096"}, "organization": {"fullName": "GlaxoSmithKline", "class": "INDUSTRY"}, "briefTitle": "Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure", "officialTitle": "COR111096, A Randomized, Double-Blind, Active-Controlled, Parallel Group, Multicenter Study Comparing the Proportion of Subjects With Stage 1 or 2 Essential Hypertension Who Achieve Target Blood Pressure While Receiving Either Carvedilol CR + Lisinopril or Lisinopril Monotherapy"}, "statusModule": {"statusVerifiedDate": "2016-11", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-03"}, "primaryCompletionDateStruct": {"date": "2008-08", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-08", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-02-14", "studyFirstSubmitQcDate": "2008-02-14", "studyFirstPostDateStruct": {"date": "2008-02-26", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-06-11", "resultsFirstSubmitQcDate": "2009-06-11", "resultsFirstPostDateStruct": {"date": "2009-08-03", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2016-11-04", "lastUpdatePostDateStruct": {"date": "2016-12-28", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "GlaxoSmithKline", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "Randomized, double-blind, parallel group, multicenter study of subjects with Stage 1 or 2 essential hypertension who are not at target blood pressure (\\<140/90mmHg) at Baseline. Subjects will be randomized to receive either carvedilol CR + lisinopril or lisinopril + placebo. Subjects will be uptitrated over a 6 week period until target blood pressure (\\<140/90mmHg) is met. The primary objective of the study is to compare the proportion of subjects who achieve target blood pressure after 6 weeks of treatment."}, "conditionsModule": {"conditions": ["Hypertension"], "keywords": ["target blood pressure", "hypertension", "COREG CR", "carvedilol CR", "Stage 1 or 2 essential hypertension", "lisinopril"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 348, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "carvedilol CR + lisinopril", "type": "EXPERIMENTAL", "interventionNames": ["Drug: carvedilol controlled release/lisinopril"]}, {"label": "lisinopril + placebo", "type": "ACTIVE_COMPARATOR", "interventionNames": ["Drug: lisinopril + placebo"]}], "interventions": [{"type": "DRUG", "name": "carvedilol controlled release/lisinopril", "description": "carvedilol CR + lisinopril given as separate pills", "armGroupLabels": ["carvedilol CR + lisinopril"]}, {"type": "DRUG", "name": "lisinopril + placebo", "description": "lisinopril plus placebo to match carvedilol CR", "armGroupLabels": ["lisinopril + placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With Mean Sitting Cuff Blood Pressure <140/90 mmHg at the End of 6 Weeks of Treatment", "description": "Sitting cuff blood pressure was calculated as the mean of three measurements taken approximately 2 minutes apart, and before the morning dose.", "timeFrame": "Week 6"}], "secondaryOutcomes": [{"measure": "Mean Change From Baseline in Sitting Systolic Blood Pressure (sSBP) and Sitting Diastolic Blood Pressure (sDBP) at Week 6", "description": "Mean change was calculated as Week 6 values minus Baseline values.", "timeFrame": "Baseline and Week 6"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female age 18-80 years; stage 1 or 2 hypertension currently receiving 0 or 1 antihypertensive medication; mean sitting systolic blood pressure \\>/=140mmHg to \\</=170mmHg, or mean sitting diastolic blood pressure \\>/=90 to \\</=105mmHg. Subjects taking one hypertensive medication had their medication withdrawn and entered a wash-out phase prior to randomization.\n\nExclusion Criteria:\n\n* Subject taking two or more antihypertensive medications, known contraindication to angiotensin-converting enzyme (ACE) inhibitors or alpha- or beta-blocker therapy, subject has Type 1 or Type 2 diabetes", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "80 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "GSK Clinical Trials", "affiliation": "GlaxoSmithKline", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "GSK Investigational Site", "city": "Mobile", "state": "Alabama", "zip": "36617", "country": "United States", "geoPoint": {"lat": 30.69436, "lon": -88.04305}}, {"facility": "GSK Investigational Site", "city": "Chandler", "state": "Arizona", "zip": "77030", "country": "United States", "geoPoint": {"lat": 33.30616, "lon": -111.84125}}, {"facility": "GSK Investigational Site", "city": "Glendale", "state": "Arizona", "zip": "85308", "country": "United States", "geoPoint": {"lat": 33.53865, "lon": -112.18599}}, {"facility": "GSK Investigational Site", "city": "Goodyear", "state": "Arizona", "zip": "85395", "country": "United States", "geoPoint": {"lat": 33.43532, "lon": -112.35821}}, {"facility": "GSK Investigational Site", "city": "Litchifield Park/Arizona", "state": "Arizona", "zip": "85340", "country": "United States", "geoPoint": {"lat": 33.49337, "lon": -112.35794}}, {"facility": "GSK Investigational Site", "city": "Phoenix", "state": "Arizona", "zip": "85032", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "GSK Investigational Site", "city": "Tucson", "state": "Arizona", "zip": "85745", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "GSK Investigational Site", "city": "Anaheim", "state": "California", "zip": "92801", "country": "United States", "geoPoint": {"lat": 33.83529, "lon": -117.9145}}, {"facility": "GSK Investigational Site", "city": "Beuna Park", "state": "California", "zip": "90620", "country": "United States", "geoPoint": {"lat": 33.86751, "lon": -117.99812}}, {"facility": "GSK Investigational Site", "city": "Fountain Valley", "state": "California", "zip": "92708", "country": "United States", "geoPoint": {"lat": 33.70918, "lon": -117.95367}}, {"facility": "GSK Investigational Site", "city": "Poway", "state": "California", "zip": "92064", "country": "United States", "geoPoint": {"lat": 32.96282, "lon": -117.03586}}, {"facility": "GSK Investigational Site", "city": "San Ramon", "state": "California", "zip": "94583", "country": "United States", "geoPoint": {"lat": 37.77993, "lon": -121.97802}}, {"facility": "GSK Investigational Site", "city": "Tustin", "state": "California", "zip": "92780", "country": "United States", "geoPoint": {"lat": 33.74585, "lon": -117.82617}}, {"facility": "GSK Investigational Site", "city": "Vista", "state": "California", "zip": "92081", "country": "United States", "geoPoint": {"lat": 33.20004, "lon": -117.24254}}, {"facility": "GSK Investigational Site", "city": "Coral Gables", "state": "Florida", "zip": "33134", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"facility": "GSK Investigational Site", "city": "Deland", "state": "Florida", "zip": "32720", "country": "United States", "geoPoint": {"lat": 29.02832, "lon": -81.30312}}, {"facility": "GSK Investigational Site", "city": "Fort Lauderdale", "state": "Florida", "zip": "33308", "country": "United States", "geoPoint": {"lat": 26.12231, "lon": -80.14338}}, {"facility": "GSK Investigational Site", "city": "Hollywood", "state": "Florida", "zip": "33023", "country": "United States", "geoPoint": {"lat": 26.0112, "lon": -80.14949}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33156", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Pembroke Pines", "state": "Florida", "zip": "33024", "country": "United States", "geoPoint": {"lat": 26.00315, "lon": -80.22394}}, {"facility": "GSK Investigational Site", "city": "Tamarac", "state": "Florida", "zip": "33321", "country": "United States", "geoPoint": {"lat": 26.21286, "lon": -80.24977}}, {"facility": "GSK Investigational Site", "city": "West Palm Beach", "state": "Florida", "zip": "33409", "country": "United States", "geoPoint": {"lat": 26.71534, "lon": -80.05337}}, {"facility": "GSK Investigational Site", "city": "Atlanta", "state": "Georgia", "zip": "30342", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "GSK Investigational Site", "city": "Savannah", "state": "Georgia", "zip": "31406", "country": "United States", "geoPoint": {"lat": 32.08354, "lon": -81.09983}}, {"facility": "GSK Investigational Site", "city": "Nampa", "state": "Idaho", "zip": "83686", "country": "United States", "geoPoint": {"lat": 43.54072, "lon": -116.56346}}, {"facility": "GSK Investigational Site", "city": "Aurora", "state": "Illinois", "zip": "60504", "country": "United States", "geoPoint": {"lat": 41.76058, "lon": -88.32007}}, {"facility": "GSK Investigational Site", "city": "Chicago", "state": "Illinois", "zip": "60607", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "GSK Investigational Site", "city": "Gillespie", "state": "Illinois", "zip": "62033", "country": "United States", "geoPoint": {"lat": 39.12977, "lon": -89.81954}}, {"facility": "GSK Investigational Site", "city": "Elkhart", "state": "Indiana", "zip": "46514", "country": "United States", "geoPoint": {"lat": 41.68199, "lon": -85.97667}}, {"facility": "GSK Investigational Site", "city": "Indianapolis", "state": "Indiana", "zip": "46250", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "GSK Investigational Site", "city": "Indianapolis", "state": "Indiana", "zip": "46260", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "GSK Investigational Site", "city": "Wichita", "state": "Kansas", "zip": "67205", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "GSK Investigational Site", "city": "Wichita", "state": "Kansas", "zip": "67207", "country": "United States", "geoPoint": {"lat": 37.69224, "lon": -97.33754}}, {"facility": "GSK Investigational Site", "city": "Paducah", "state": "Kentucky", "zip": "42003", "country": "United States", "geoPoint": {"lat": 37.08339, "lon": -88.60005}}, {"facility": "GSK Investigational Site", "city": "Slidell", "state": "Louisiana", "zip": "70458", "country": "United States", "geoPoint": {"lat": 30.27519, "lon": -89.78117}}, {"facility": "GSK Investigational Site", "city": "Columbia", "state": "Maryland", "zip": "21045", "country": "United States", "geoPoint": {"lat": 39.24038, "lon": -76.83942}}, {"facility": "GSK Investigational Site", "city": "Butte", "state": "Montana", "zip": "59701", "country": "United States", "geoPoint": {"lat": 46.00382, "lon": -112.53474}}, {"facility": "GSK Investigational Site", "city": "Omaha", "state": "Nebraska", "zip": "68134", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "GSK Investigational Site", "city": "Las Vegas", "state": "Nevada", "zip": "89016", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "GSK Investigational Site", "city": "Las Vegas", "state": "Nevada", "zip": "89119", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "GSK Investigational Site", "city": "Albuquerque", "state": "New Mexico", "zip": "87102", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}, {"facility": "GSK Investigational Site", "city": "Buffalo", "state": "New York", "zip": "14209", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"facility": "GSK Investigational Site", "city": "Buffalo", "state": "New York", "zip": "14215", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"facility": "GSK Investigational Site", "city": "East Syracuse", "state": "New York", "zip": "13057", "country": "United States", "geoPoint": {"lat": 43.06534, "lon": -76.07853}}, {"facility": "GSK Investigational Site", "city": "New York", "state": "New York", "zip": "10075", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "GSK Investigational Site", "city": "Westfield", "state": "New York", "zip": "14787", "country": "United States", "geoPoint": {"lat": 42.32228, "lon": -79.5781}}, {"facility": "GSK Investigational Site", "city": "Raleigh", "state": "North Carolina", "zip": "27609", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"facility": "GSK Investigational Site", "city": "Fargo", "state": "North Dakota", "zip": "58103", "country": "United States", "geoPoint": {"lat": 46.87719, "lon": -96.7898}}, {"facility": "GSK Investigational Site", "city": "Cincinnati", "state": "Ohio", "zip": "45219", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "GSK Investigational Site", "city": "Corvallis", "state": "Oregon", "zip": "97330", "country": "United States", "geoPoint": {"lat": 44.56457, "lon": -123.26204}}, {"facility": "GSK Investigational Site", "city": "Altoona", "state": "Pennsylvania", "zip": "16602", "country": "United States", "geoPoint": {"lat": 40.51868, "lon": -78.39474}}, {"facility": "GSK Investigational Site", "city": "Havertown", "state": "Pennsylvania", "zip": "19083", "country": "United States", "geoPoint": {"lat": 39.98095, "lon": -75.30852}}, {"facility": "GSK Investigational Site", "city": "Jersey Shore", "state": "Pennsylvania", "zip": "17740", "country": "United States", "geoPoint": {"lat": 41.20202, "lon": -77.26442}}, {"facility": "GSK Investigational Site", "city": "Lansdale", "state": "Pennsylvania", "zip": "19446", "country": "United States", "geoPoint": {"lat": 40.2415, "lon": -75.28379}}, {"facility": "GSK Investigational Site", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19154", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "GSK Investigational Site", "city": "Columbia", "state": "South Carolina", "zip": "29201", "country": "United States", "geoPoint": {"lat": 34.00071, "lon": -81.03481}}, {"facility": "GSK Investigational Site", "city": "Columbia", "state": "South Carolina", "zip": "29204", "country": "United States", "geoPoint": {"lat": 34.00071, "lon": -81.03481}}, {"facility": "GSK Investigational Site", "city": "Manning", "state": "South Carolina", "zip": "29102", "country": "United States", "geoPoint": {"lat": 33.69516, "lon": -80.21091}}, {"facility": "GSK Investigational Site", "city": "Johnson City", "state": "Tennessee", "zip": "37601", "country": "United States", "geoPoint": {"lat": 36.31344, "lon": -82.35347}}, {"facility": "GSK Investigational Site", "city": "Austin", "state": "Texas", "zip": "78705", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "GSK Investigational Site", "city": "Georgetown", "state": "Texas", "zip": "78626", "country": "United States", "geoPoint": {"lat": 30.63269, "lon": -97.67723}}, {"facility": "GSK Investigational Site", "city": "Grand Prairie", "state": "Texas", "zip": "75052", "country": "United States", "geoPoint": {"lat": 32.74596, "lon": -96.99778}}, {"facility": "GSK Investigational Site", "city": "Houston", "state": "Texas", "zip": "77081", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78224", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78229", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "Sugar Land", "state": "Texas", "zip": "77479", "country": "United States", "geoPoint": {"lat": 29.61968, "lon": -95.63495}}, {"facility": "GSK Investigational Site", "city": "Draper", "state": "Utah", "zip": "84020", "country": "United States", "geoPoint": {"lat": 40.52467, "lon": -111.86382}}, {"facility": "GSK Investigational Site", "city": "Magna", "state": "Utah", "zip": "84044", "country": "United States", "geoPoint": {"lat": 40.70911, "lon": -112.10161}}, {"facility": "GSK Investigational Site", "city": "Salt Lake City", "state": "Utah", "zip": "84109", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "GSK Investigational Site", "city": "Salt Lake City", "state": "Utah", "zip": "84121", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "GSK Investigational Site", "city": "Sandy", "state": "Utah", "zip": "84094", "country": "United States", "geoPoint": {"lat": 40.59161, "lon": -111.8841}}, {"facility": "GSK Investigational Site", "city": "Bellingham/Washington", "state": "Washington", "zip": "98226", "country": "United States", "geoPoint": {"lat": 48.75955, "lon": -122.48822}}, {"facility": "GSK Investigational Site", "city": "Gig Harbor", "state": "Washington", "zip": "98335", "country": "United States", "geoPoint": {"lat": 47.32926, "lon": -122.58013}}, {"facility": "GSK Investigational Site", "city": "Olympia", "state": "Washington", "zip": "98502-8151", "country": "United States", "geoPoint": {"lat": 47.03787, "lon": -122.9007}}, {"facility": "GSK Investigational Site", "city": "Tacoma", "state": "Washington", "zip": "98405", "country": "United States", "geoPoint": {"lat": 47.25288, "lon": -122.44429}}, {"facility": "GSK Investigational Site", "city": "Beloit", "state": "Wisconsin", "zip": "53511", "country": "United States", "geoPoint": {"lat": 42.50835, "lon": -89.03178}}]}, "referencesModule": {"references": [{"type": "BACKGROUND", "citation": "GSK has submitted manuscripts of these study results to peer-reviewed scientific journals which were not accepted for publication. GSK is providing the attached study results summary with a conclusion."}], "seeAlsoLinks": [{"label": "Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.", "url": "https://www.clinicalstudydatarequest.com"}], "availIpds": [{"id": "COR111096", "type": "Statistical Analysis Plan", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Study Protocol", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Annotated Case Report Form", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Individual Participant Data Set", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Informed Consent Form", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Clinical Study Report", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "COR111096", "type": "Dataset Specification", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site."}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Lisinopril", "description": "Lisinopril monotherapy (10, 20, or 40 mg once daily)"}, {"id": "FG001", "title": "Carvedilol CR + Lisinopril", "description": "Carvedilol controlled release (CR) + lisinopril (20 + 10, 20 + 20, or 40 + 20 mg once daily)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "216"}, {"groupId": "FG001", "numSubjects": "216"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "197"}, {"groupId": "FG001", "numSubjects": "192"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "19"}, {"groupId": "FG001", "numSubjects": "24"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Consent withdrawn", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "3"}]}, {"type": "Met protocol-defined stopping criteria", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "9"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Lisinopril", "description": "Lisinopril monotherapy (10, 20, or 40 mg once daily)"}, {"id": "BG001", "title": "Carvedilol CR + Lisinopril", "description": "Carvedilol controlled release (CR) + lisinopril (20 + 10, 20 + 20, or 40 + 20 mg once daily)"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "216"}, {"groupId": "BG001", "value": "216"}, {"groupId": "BG002", "value": "432"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "54.0", "spread": "11.9"}, {"groupId": "BG001", "value": "54.1", "spread": "9.8"}, {"groupId": "BG002", "value": "54.1", "spread": "10.9"}]}]}]}, {"title": "Gender", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "95"}, {"groupId": "BG001", "value": "95"}, {"groupId": "BG002", "value": "190"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "121"}, {"groupId": "BG001", "value": "121"}, {"groupId": "BG002", "value": "242"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "African American/African Heritage (AA/AH)", "categories": [{"measurements": [{"groupId": "BG000", "value": "45"}, {"groupId": "BG001", "value": "29"}, {"groupId": "BG002", "value": "74"}]}]}, {"title": "American Indian or Alaska Native", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "3"}]}]}, {"title": "Japanese/East Asian/South East Asian Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "16"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "22"}]}]}, {"title": "Mixed Asian Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "150"}, {"groupId": "BG001", "value": "178"}, {"groupId": "BG002", "value": "328"}]}]}, {"title": "AA/AH & American Indian or Alaska Native", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}, {"title": "AA/AH & American Indian or Alaska Native & White", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "AA/AH & White", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}]}]}, {"title": "Baseline Blood Pressure", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mm/Hg", "classes": [{"title": "Baseline Sitting Systolic Blood Pressure (SBP)", "categories": [{"measurements": [{"groupId": "BG000", "value": "149.8", "spread": "10.25"}, {"groupId": "BG001", "value": "148.8", "spread": "10.30"}, {"groupId": "BG002", "value": "149.3", "spread": "10.27"}]}]}, {"title": "Baseline Sitting Diastolic Blood Pressure (DBP)", "categories": [{"measurements": [{"groupId": "BG000", "value": "92.2", "spread": "8.12"}, {"groupId": "BG001", "value": "92.2", "spread": "6.84"}, {"groupId": "BG002", "value": "92.2", "spread": "7.50"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With Mean Sitting Cuff Blood Pressure <140/90 mmHg at the End of 6 Weeks of Treatment", "description": "Sitting cuff blood pressure was calculated as the mean of three measurements taken approximately 2 minutes apart, and before the morning dose.", "populationDescription": "Intent to Treat Efficacy (ITTE) Population: all randomized participants with efficacy (vital signs) data after a minimum of 4 weeks of treatment", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "Week 6", "groups": [{"id": "OG000", "title": "Lisinopril", "description": "Lisinopril monotherapy (10, 20, or 40 mg once daily)"}, {"id": "OG001", "title": "Carvedilol CR + Lisinopril", "description": "Carvedilol controlled release (CR) + lisinopril (20 + 10, 20 + 20, or 40 + 20 mg once daily)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"title": "Responders (mean BP <140/90 mmHg)", "categories": [{"measurements": [{"groupId": "OG000", "value": "139"}, {"groupId": "OG001", "value": "137"}]}]}, {"title": "Non-responders (SBP >/=140 mmHg or DBP >/=90 mmHg)", "categories": [{"measurements": [{"groupId": "OG000", "value": "64"}, {"groupId": "OG001", "value": "64"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.8822", "statisticalMethod": "Regression, Logistic", "paramType": "Odds Ratio (OR)", "paramValue": "0.968", "ciPctValue": "95", "ciLowerLimit": "0.63", "ciUpperLimit": "1.49"}]}, {"type": "SECONDARY", "title": "Mean Change From Baseline in Sitting Systolic Blood Pressure (sSBP) and Sitting Diastolic Blood Pressure (sDBP) at Week 6", "description": "Mean change was calculated as Week 6 values minus Baseline values.", "populationDescription": "ITTE", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline and Week 6", "groups": [{"id": "OG000", "title": "Lisinopril", "description": "Lisinopril monotherapy (10, 20, or 40 mg once daily)"}, {"id": "OG001", "title": "Carvedilol CR + Lisinopril", "description": "Carvedilol controlled release (CR) + lisinopril (20 + 10, 20 + 20, or 40 + 20 mg once daily)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"title": "sSBP (mmHg)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-17.05", "spread": "12.27"}, {"groupId": "OG001", "value": "-16.07", "spread": "13.49"}]}]}, {"title": "sDBP (mmHg)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-10.15", "spread": "7.52"}, {"groupId": "OG001", "value": "-9.14", "spread": "9.65"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "1", "description": "The frequency threshold for reporting Other Adverse Events is 1% in either treatment group.", "eventGroups": [{"id": "EG000", "title": "Lisinopril", "description": "Lisinopril monotherapy (10, 20, or 40 mg once daily)", "seriousNumAffected": 2, "otherNumAffected": 50}, {"id": "EG001", "title": "Carvedilol CR + Lisinopril", "description": "Carvedilol controlled release (CR) + lisinopril (20 + 10, 20 + 20, or 40 + 20 mg once daily)", "seriousNumAffected": 3, "otherNumAffected": 54}], "seriousEvents": [{"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 216}]}, {"term": "Gastroesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Meningitis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 216}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Suicide attempt", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 216}]}], "otherEvents": [{"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 216}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 13, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 216}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 10, "numAtRisk": 216}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 216}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 216}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 216}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 216}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 216}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 216}]}, {"term": "Flushing", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 216}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 216}]}, {"term": "Hyperhydrosis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 216}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 216}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 216}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 216}]}, {"term": "Dyspepsia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 216}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 216}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 216}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "GSK Response Center", "organization": "GlaxoSmithKline", "phone": "866-435-7343"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-26"}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}, {"id": "D000075222", "term": "Essential Hypertension"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M1470", "name": "Essential Hypertension", "asFound": "Essential Hypertension", "relevance": "HIGH"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000077261", "term": "Carvedilol"}, {"id": "D000017706", "term": "Lisinopril"}], "ancestors": [{"id": "D000000319", "term": "Adrenergic beta-Antagonists"}, {"id": "D000018674", "term": "Adrenergic Antagonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000000975", "term": "Antioxidants"}, {"id": "D000020011", "term": "Protective Agents"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000014665", "term": "Vasodilator Agents"}, {"id": "D000058668", "term": "Adrenergic alpha-1 Receptor Antagonists"}, {"id": "D000000317", "term": "Adrenergic alpha-Antagonists"}, {"id": "D000000806", "term": "Angiotensin-Converting Enzyme Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000002316", "term": "Cardiotonic Agents"}], "browseLeaves": [{"id": "M1718", "name": "Carvedilol", "asFound": "Depressive Disorder", "relevance": "HIGH"}, {"id": "M19924", "name": "Lisinopril", "asFound": "Polycystic", "relevance": "HIGH"}, {"id": "M3671", "name": "Adrenergic beta-Antagonists", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M20755", "name": "Adrenergic Antagonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M4292", "name": "Antioxidants", "relevance": "LOW"}, {"id": "M21869", "name": "Protective Agents", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}, {"id": "M29194", "name": "Adrenergic alpha-1 Receptor Antagonists", "relevance": "LOW"}, {"id": "M3669", "name": "Adrenergic alpha-Antagonists", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M4134", "name": "Angiotensin-Converting Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M5572", "name": "Cardiotonic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "CaAg", "name": "Cardiotonic Agents"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}